"尽管有7年低息政策，但如果买i6的话，我更推荐选择5年的购车方案。"1月26日，《每日经济新闻》记者走访车市时，北京地区一位理想汽车销售人员 这样说。 上述销售人员提及的"7年低息政策"，自2026年开年以来已成为新能源汽车市场竞争的焦点之一。进入1月后，特斯拉、小米汽车、理想汽车、小鹏汽车等 品牌纷纷推出或进一步强化了长达7年的低息购车金融方案，这一举措将传统汽车贷款周期普遍延长了2至3年。 得益于更长的贷款周期，消费者每月的还款额度得以大幅降低：小米汽车YU7月供低至2593元起；小鹏汽车全系月供低至1355元起；理想汽车月供低至 2578元起；特斯拉Model 3/Y/Y L月供低至1918元起。 有分析认为，在消费者仍持观望态度的市场环境下，车企面临着库存积压的压力。为刺激市场需求、提前锁定订单，车企纷纷采用贴息手段，这一举措旨 在抢占市场先机。然而，超长期低息方案的实际让利范围、成本分摊机制及对行业竞争秩序的潜在影响，仍需市场进一步验证。 特斯拉金融方案优势相对明显 据记者了解，特斯拉推出了两种首付标准不同的方案：根据首付情况不同，对应的年化费率和折合年化利率也有所差异。具体来说，首付比例较低时（ ...

证券日报网讯1月27日，威高骨科在互动平台回答投资者提问时表示，2025COA会议上公司举行的是威 高旗下北京威高智慧科技有限公司的手术机器人投放签约仪式，并未产生实际销售。该公司目前不在上 市公司合并报表范围内。该骨科机器人采用AI三维建模，自动拾取特征点，匹配算法优化，末端动力 强劲，更贴合临床手术需求。公司正加强与集团骨科手术机器人公司的市场对接，进一步促进产品教育 和投放入院。公司于2025年12月收购了杰思拜尔公司，进一步补充和夯实了公司骨科微创产线，其中核 心技术产品之一的五合一超声骨动力系统于2025年下半年取证，该系统集成了超声骨刀、动力、刨削、 灌注泵和负压吸收五大功能，搭载中心频率自动调整与频率自动跟踪快速复位技术，灌注与负压系统可 实现智能联动，体现了较好的技术先进性，与公司产品具有高协同性。因在2025年底杰斯拜尔尚未完成 股权变更，本产品的销售收入不会在上市公司2025年年报里体现。 ...

Core Viewpoint - Weigao Orthopedics is actively engaged in clinical research and technical collaboration in the field of surgical robots for spinal and joint surgeries, having authorized key technical data of its core products to multiple surgical robot companies [1] Group 1 - Weigao Orthopedics has been asked by investors about its collaboration with surgical robot companies [1] - The company has established clinical research and technical cooperation in the field of surgical robots [1] - Key technical data of core products has been authorized to several surgical robot companies [1]

Group 1 - The core point of the article is that Weigao Orthopedics is currently not generating sales from its surgical robot products, which are managed by the group company, and that new products like the ultrasonic bone knife will not reflect in the 2024 annual report but are expected to be sold by 2026 [1] Group 2 - Weigao Orthopedics has engaged in various collaborations with surgical robot companies, indicating a strategic approach to entering the surgical robotics market [1] - The company has recently acquired a minimally invasive orthopedic production line, which includes the ultrasonic bone knife from Jiesibai'er [1] - The strategic signing ceremony for the surgical robot deployment in hospitals took place at the 2025 COA conference, highlighting the company's future plans in this sector [1]

Group 1 - The company plans to invest 60 million yuan, accounting for 20% of the total capital contribution, in a partnership with several private equity firms to establish Jiaxing Xinwei Chuangying Equity Investment Partnership (Limited Partnership) [1] - The partnership has completed the necessary business registration and obtained a business license from the local market supervision authority, with a total capital of 300 million yuan [2] - The partnership is yet to have specific investment projects and the company has not yet made its capital contribution [2][4] Group 2 - The company will closely monitor the fund's operations, management, investment decisions, and post-investment management to mitigate investment risks [3] - There is uncertainty regarding the investment progress and project completion due to various factors such as macroeconomic conditions and industry cycles [3] - As of now, there are no specific external investment projects associated with the partnership [4]

证券代码：688161 证券简称：威高骨科 公告编号：2026-001 山东威高骨科材料股份有限公司 与私募基金合作投资事项进展公告 重要内容提示： 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 公司近日收到信金顺致私募基金管理（北京）有限公司的通知，嘉兴信威创 盈股权投资合伙企业(有限合伙)已完成相关工商登记手续并取得平湖市市场监 督管理局颁发的《营业执照》。具体信息如下： 企业名称：嘉兴信威创盈股权投资合伙企业(有限合伙) 执行事务合伙人：信金顺致私募基金管理(北京)有限公司(委派代表:高卓 群) 统一社会信用代码：91330482MAK5QL1F69 出资额：叁亿元整 企业类型：有限合伙企业 投资标的名称 嘉兴信威创盈股权投资合伙企业(有限合伙) 投资金额（万元） 6,000.00 投资进展阶段 完成 终止 交易要素变更 √进展 特别风险提示（如有请勾选） 募集失败 未能完成备案登记 提前终止 发生重大变更 其他： 一、合作投资基本概述情况 山东威高骨科材料股份有限公司（以下简称"公司"）拟与信金顺致私募基 金管理（北 ...

Group 1 - The core viewpoint of the news is that Weigao Orthopedics has seen a stock price increase of 5.01%, reaching 29.32 CNY per share, with a total market capitalization of 11.728 billion CNY [1] - Weigao Orthopedics specializes in the research, production, and sales of orthopedic medical devices, with its main revenue sources being joints (29.01%), spine (28.99%), sports medicine and tissue repair (19.11%), trauma (16.64%), and others (6.10%) [1] - The company was established on April 6, 2005, and went public on June 30, 2021 [1] Group 2 - Among the top ten circulating shareholders of Weigao Orthopedics, Penghua Fund has a fund that entered the list, holding 1.0961 million shares, which is 0.27% of the circulating shares [2] - The Penghua Medical Technology Stock A fund has achieved a year-to-date return of 68.28%, ranking 197 out of 4189 in its category [2] - The fund was established on June 2, 2015, and has a current scale of 1.921 billion CNY [2] Group 3 - The fund manager of Penghua Medical Technology Stock A is Jin Xiaofei, who has a tenure of 9 years and 198 days, with the fund's total asset size at 5.375 billion CNY [3] - During Jin Xiaofei's tenure, the best fund return was 234.14%, while the worst return was -0.92% [3]

Group 1 - The Shanghai Composite Index is at 4005.73 points, above the annual line, with an increase of 0.93% [1] - The total trading volume of A-shares today is 1,402.986 billion yuan [1] - A total of 154 A-shares have surpassed the annual line, with notable stocks showing significant deviation rates including Yingkang Life, Gangtong Medical, and Beilu Pharmaceutical at 10.63%, 10.61%, and 9.97% respectively [1] Group 2 - The top three stocks with the highest deviation rates from the annual line are: - Yingkang Life (12.85% increase, 10.63% deviation) - Gangtong Medical (11.91% increase, 10.61% deviation) - Beilu Pharmaceutical (10.20% increase, 9.97% deviation) [1] - Other notable stocks with significant increases include: - Guanhao Biological (14.87% increase, 8.29% deviation) - Baichu Electronics (6.95% increase, 6.79% deviation) [1] - Stocks with smaller deviation rates that have just crossed the annual line include *ST Yedao, Shiyan Institute, and Shanxi Securities [1]

Market Performance - The US stock market continued its post-Christmas pullback, with all three major indices closing lower, marking a subdued end to 2025. The S&P 500 index fell by 0.74% to 6845.5 points, the Nasdaq Composite dropped by 0.76% to 23241.99 points, and the Dow Jones Industrial Average decreased by 0.63% to 48063.29 points [1]. - For the year, the S&P 500 recorded an annual increase of 16.39%, while the Nasdaq managed a 20.36% rise, achieving over 20% growth for three consecutive years. The Dow Jones also rose by 12.97%, marking a similar performance for the third year in a row [3]. Individual Stock Performance - Among the top performers in the S&P 500, four storage giants—SanDisk, Western Digital, Micron Technology, and Seagate Technology—led the annual gains. Semiconductor stocks like Lam Research, AI application leader Palantir, and Comfort Systems, which provides HVAC solutions for data centers, also featured prominently [3]. - In the tech sector, only Google and Nvidia among the "Big Seven" tech companies outperformed the benchmark index in 2025 [8]. Commodity and Sector Movements - US silver futures experienced a significant drop of 9% due to a second margin increase by the CME Group within a week, negatively impacting the mining sector. Companies like Endeavour Silver and Silvercorp Metals saw declines of over 4% and 2.8%, respectively [11]. Chinese Stocks - The Nasdaq Golden Dragon China Index closed down 1.13% but recorded an annual increase of 11.33%. Notable Chinese stocks included Alibaba, which rose over 75%, and Netease, which increased by 58.28% [12]. Corporate News - Warren Buffett officially retired as CEO of Berkshire Hathaway on December 31, 2025, after a long tenure, although he will remain as chairman of the board [13]. - Tesla achieved a milestone with a driver completing a coast-to-coast journey using full self-driving technology, marking a significant advancement in autonomous vehicle capabilities [15]. - Nvidia and AMD are expected to enter a "year-long price increase cycle" for GPUs, driven by rising memory costs, with flagship models potentially reaching prices as high as $5000 [16]. - Trump Media & Technology Group announced plans to issue a new cryptocurrency to shareholders, despite a significant annual decline in stock value [17]. - Brookfield Asset Management is launching a cloud computing business to challenge tech giants like Amazon, aiming to reduce AI development costs [18]. - Uber is in talks to acquire the parking app SpotHero, which could create synergies between ride-hailing and parking services [19].

Group 1 - The company held its third extraordinary general meeting of shareholders on December 29, 2025, in Shanghai, with no resolutions being rejected [2] - The meeting was convened by the board of directors and conducted in accordance with the Company Law and the company's articles of association, utilizing both on-site and online voting methods [2][3] - The meeting was attended by 7 out of 8 current directors, with the board secretary and other executives present, while one independent director was absent due to work commitments [3] Group 2 - A key resolution passed during the meeting was regarding the change of certain fundraising projects and the acquisition of equity in Suzhou Jiesibai Medical Technology Co., Ltd., which was approved [4] - The voting for the resolutions was conducted as ordinary resolutions, requiring more than half of the voting shares represented at the meeting to pass [5] Group 3 - The company signed a tripartite supervision agreement for the storage of raised funds, ensuring effective management and protection of investor rights [7][11] - The company was approved to publicly issue 41.4142 million shares at a price of RMB 36.22 per share, raising a total of RMB 1.5 billion, with a net amount of RMB 1.382 billion after deducting issuance costs [8][9] - A special account for the raised funds was established, which is exclusively for the storage and use of funds related to the acquisition and capital increase project [10][12] Group 4 - The tripartite agreement involves the company, China Agricultural Bank, and Huatai United Securities, outlining the management and supervision of the raised funds [12] - The agreement stipulates that any withdrawal exceeding RMB 50 million or 20% of the net raised funds must be reported to the supervising party [14] - The agreement will remain effective until all funds are fully utilized and the account is legally closed [15]